DaVita Clinical Research has launched a biospecimen grant program that will provide clinical-trial quality biospecimens and de-identified annotated data to up to 10 qualified academic medical centers involved in kidney disease research. They will be accepting applications for the program through Sept. 30th, 2015. No funds will be awarded.

The goal of BioReG is to have the specimens and data used to research factors or characteristics that contribute to morbidity and mortality in individuals with chronic kidney disease.

Find more information about the program.